How do I buy Vertex Pharmaceuticals (VRTX) stock?

You can purchase shares of Vertex Pharmaceuticals (NASDAQ:VRTX) through any online brokerage.View our list of the best stock brokerages

Who are Vertex Pharmaceuticals (VRTX) competitors?

Other companies in Vertex Pharmaceuticals’s space includes: Exact Sciences Corp (NASDAQ:EXAS), BeOne Medicines Ltd (NASDAQ:ONC), Neurocrine Biosciences Inc (NASDAQ:NBIX), Ionis Pharmaceuticals Inc (NASDAQ:IONS) and Roivant Sciences Ltd (NASDAQ:ROIV).

What is the forecast, or price target, for Vertex Pharmaceuticals (VRTX) stock?

Vertex Pharmaceuticals has a consensus price target of $503.36.

What is the current price for Vertex Pharmaceuticals (VRTX)?

The stock price for Vertex Pharmaceuticals (NASDAQ: VRTX) is $441.2 last updated January 16, 2026 at 6:44 PM EST.

Does Vertex Pharmaceuticals (VRTX) pay a dividend?

There are no upcoming dividends for Vertex Pharmaceuticals.

When is Vertex Pharmaceuticals (NASDAQ:VRTX) reporting earnings?

Vertex Pharmaceuticals does not have any upcoming earnings scheduled.

Is Vertex Pharmaceuticals (VRTX) going to split?

There is no upcoming split for Vertex Pharmaceuticals.

What sector and industry does Vertex Pharmaceuticals (VRTX) operate in?

Vertex Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Vertex Pharmaceuticals (VRTX) Stock Price, Quote, News & History

Bulls vs Bears

Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Name

Revenue

Change

Gross

Change

EBITDA

Change

EBIT

Change

Earnings

Change

About

Sector

Health Care

Industry

Biotechnology

Vertex Pharmaceuticals is a global biotechnology company that discovers and develops small-molecule drugs for the treatment of serious diseases. Its key drugs are Kalydeco, Orkambi, Symdeko, and Trikafta/Kaftrio, and Alyftrek for cystic fibrosis, whe...

Comments